Published
Article written by
/2021/12/14/61b8b9accb57c_france-3.png)
The Merck laboratory announced on Wednesday October 19 that it had been indicted for aggravated deception in connection with the unknown side effects of its drug: Levothyrox.
On Sylvie’s cell phone Chereauthis Wednesday, October 19, founder of the Collectif des Victimes du Levothyrox d’Occitanie, receives congratulatory messages on her phone. She has been fighting against the new formula of the drug and her Merck laboratory for years. The indictment of the latter is a victory. In 2017, Merck changed the formula of Levothyrox, the only drug available in France for thyroid patients. Except that several thousand of them complain of serious side effects.
In 2020, the laboratory is sentenced for lack of information. This Wednesday, October 19, he is indicted for aggravated deception. The lab says it will “take cognizance of all the elements of this file and provide all the necessary details in order to establish that no criminal offense (…) has been committed”. For patient associations, this is only a first step. They hope that justice will also consider the case of theANSMdrug agency, whom they accuse of having turned a blind eye.